Cargando…

LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer

SIMPLE SUMMARY: The objective of the study was to investigate the possibility of lncRNA HCP5-encoded peptide/protein and the role of the resulting product in triple-negative breast cancer. Our study revealed that lncRNA HCP5 encodes a 132-amino acid sequence, referred to as HCP5-132aa, which enhance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xiao, Yu, Zhengling, Xing, Jiani, Liu, Haizhou, Zhou, Shunheng, Huang, Yu’e, Lin, Jing, Jiang, Wei, Wang, Lihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046773/ https://www.ncbi.nlm.nih.gov/pubmed/36980766 http://dx.doi.org/10.3390/cancers15061880

Ejemplares similares

LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p
por: Wang, Lihong, et al.
Publicado: (2019)

LncRNA-Encoded Peptide: Functions and Predicting Methods
por: Xing, Jiani, et al.
Publicado: (2021)

Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types
por: Liu, Haizhou, et al.
Publicado: (2019)

ncFO: A Comprehensive Resource of Curated and Predicted ncRNAs Associated with Ferroptosis
por: Zhou, Shunheng, et al.
Publicado: (2023)

LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
por: Wang, Yirong, et al.
Publicado: (2019)

LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge
por: Liang, Leilei, et al.
Publicado: (2018)

Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks
por: Zhou, Shunheng, et al.
Publicado: (2021)

LncRNA HCP5 : A Potential Biomarker for Diagnosing Gastric Cancer
por: Qin, Shiyi, et al.
Publicado: (2021)

Correction: LncRNA HCP5A promotes follicular thyroid carcinoma progression via miRNAs sponge
por: Liang, Leilei, et al.
Publicado: (2019)

Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis
por: Bai, Ni, et al.
Publicado: (2020)

LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer
por: Zhao, Cheng, et al.
Publicado: (2020)

Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells
por: Hao, Jun-Feng, et al.
Publicado: (2020)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

LncRNA HCP5 enhances the proliferation and migration of cervical cancer via miR-216a-5p/CDC42 axis
por: Li, Xiaomin, et al.
Publicado: (2022)

A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
por: Wei, Jianming, et al.
Publicado: (2021)

LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis
por: Hu, Shao-pu, et al.
Publicado: (2021)

LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells
por: Yang, Chen, et al.
Publicado: (2022)

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis
por: Chen, Weiwei, et al.
Publicado: (2021)

A Prognostic Ferroptosis-Related lncRNA Model Associated With Immune Infiltration in Colon Cancer
por: Lu, Jianzhong, et al.
Publicado: (2022)

The LINK-A lncRNA Activates Normoxic HIF1α Signaling in Triple-negative Breast Cancer
por: Lin, Aifu, et al.
Publicado: (2016)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
por: Hu, Xue, et al.
Publicado: (2022)

lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis
por: Wang, Yu, et al.
Publicado: (2022)

Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer
por: Guo, Jiani, et al.
Publicado: (2021)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2022)

Serum exosomal lncRNA XIST is a potential non‐invasive biomarker to diagnose recurrence of triple‐negative breast cancer
por: Lan, Fengming, et al.
Publicado: (2021)

Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor
por: Liu, Hengchen, et al.
Publicado: (2021)

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer
por: Xu, Ying, et al.
Publicado: (2022)

Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells [Retraction]
Publicado: (2023)

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
por: Zhang, Jianhua, et al.
Publicado: (2021)

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer
por: Shaath, Hibah, et al.
Publicado: (2021)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Predicting lncRNA-miRNA Interaction via Graph Convolution Auto-Encoder
por: Huang, Yu-An, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uneggco3gjdohct01o534tphv8